Menza et al. BMC Public Health 2010, 10:774 http://www.biomedcentral.com/1471-2458/10/774 References 1. Burcham JL, Tindall B, Marmor M, Cooper DA, Berry G, Penny R: Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual men. Med J Aust 1989, 150(11):634-639. 2. Chesney MA, Barrett DC, Stall R: Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men. Am J Public Health 1998, 88(1):113-116. 3. Plankey MW, Ostrow DG, Stall R, Cox C, Li X, Peck JA, Jacobson LP: The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2007, 45(1):85-92. 4. Koblin BA, Husnik MJ, Colfax G, Huang Y, Madison M, Mayer K, Barresi PJ, Coates TJ, Chesney MA, Buchbinder S: Risk factors for HIV infection among men who have sex with men. AIDS 2006, 20(5):731-739. 5. SFDPH: HIV/AIDS Epidemiology Annual Report. San Francisco, CA: HIV/ AIDS Statistics, Epidemiology, and Intervention Research Section, San Francisco Department of Public Health; 2005. 6. Menza TW, Hughes JP, Celum CL, Golden MR: Prediction of HIV acquisition among men who have sex with men. Sex Transm Dis 2009, 36(9):547-555. 7. Semple SJ, Patterson TL, Grant I: Motivations associated with methamphetamine use among HIV+ men who have sex with men. J Subst Abuse Treat 2002, 22(3):149-156. 8. Paul JP, Stall R, Davis F: Sexual risk for HIV transmission among gay/ bisexual men in substance-abuse treatment. AIDS Educ Prev 1993, 5(1):11-24. 9. Colfax G, Shoptaw S: The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep 2005, 2(4):194-199. 10. Reback CJ, Larkins S, Shoptaw S: Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment. AIDS Behav 2004, 8(1):87-98. 11. Lyons T, Chandra G, Goldstein J: Stimulant use and HIV risk behavior: the influence of peer support group participation. AIDS Educ Prev 2006, 18(5):461-473. 12. Petry NM, Tedford J, Martin B: Reinforcing compliance with non-drug- related activities. J Subst Abuse Treat 2001, 20(1):33-44. 13. Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST: A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006, 101(2):192-203. 14. Prendergast M, Podus D, Finney J, Greenwell L, Roll J: Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006, 101(11):1546-1560. 15. Shoptaw S, Reback CJ, Peck JA, Yang X, Rotheram-Fuller E, Larkins S, Veniegas RC, Freese TE, Hucks-Ortiz C: Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend 2005, 78(2):125-134. 16. Menza TW, Colfax G, Shoptaw S, Fleming M, Guzman R, Klausner JD, Gorbach P, Golden MR: Interest in a methamphetamine intervention among men who have sex with men. Sex Transm Dis 2007, 34(4):209-214. 17. Strona FV, McCright J, Hjord H, Ahrens K, Tierney S, Shoptaw S, Klausner JD: The acceptability and feasibility of the Positive Reinforcement Opportunity Project, a community-based contingency management methamphetamine treatment program for gay and bisexual men in San Francisco. J Psychoactive Drugs 2006, , Suppl 3: 377-383. 18. Shoptaw S, Klausner JD, Reback CJ, Tierney S, Stansell J, Hare CB, Gibson S, Siever M, King WD, Kao U, et al: A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence. BMC Public Health 2006, 6:214. 19. Roll JM, Shoptaw S: Contingency management: schedule effects. Psychiatry Res 2006, 144(1):91-93. 20. Petry NM: A comprehensive guide to the application of contingency management procedures in clinical settings. Drug Alcohol Depend 2000, 58(1-2):9-25. 21. Roll JM, Petry NM, Stitzer ML, Brecht ML, Peirce JM, McCann MJ, Blaine J, MacDonald M, DiMaria J, Lucero L, et al: Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry 2006, 163(11):1993-1999. 22. Huestis MA, Cone EJ: Methamphetamine disposition in oral fluid, plasma, and urine. Ann N Y Acad Sci 2007, 1098:104-121. Page 12 of 13 23. Preston KL, Epstein DH, Cone EJ, Wtsadik AT, Huestis MA, Moolchan ET: Urinary elimination of cocaine metabolites in chronic cocaine users during cessation. J Anal Toxicol 2002, 26(7):393-400. 24. Oncology Biostatistics: Randomization. [http://www.cancerbiostats.onc. jhmi.edu/software.cfm]. 25. Prentice RL, Thomson CA, Caan B, Hubbell FA, Anderson GL, Beresford SA, Pettinger M, Lane DS, Lessin L, Yasmeen S, et al: Low-fat dietary pattern and cancer incidence in the Women’s Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst 2007, 99(20):1534-1543. 26. Sexually transmitted disease and HIV screening guidelines for men who have sex with men. Sex Transm Dis 2001, 28(8):457-459. 27. Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep 2001, 50(RR-19):1-57, quiz CE51-19a51-CE56-19a51. 28. Golden MR, Brewer DD, Kurth A, Holmes KK, Handsfield HH: Importance of sex partner HIV status in HIV risk assessment among men who have sex with men. J Acquir Immune Defic Syndr 2004, 36(2):734-742. 29. Menza TW, Golden MR: Test-retest reliability of an audio computer assisted self-interview among high-risk men who have sex with men. 17th Meeting of the International Society for Sexually Transmitted Disease Research: 2007 Seattle, WA; 2007. 30. McNutt LA, Wu C, Xue X, Hafner JP: Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003, 157(10):940-943. 31. Maldonado G, Greenland S: Simulation study of confounder-selection strategies. Am J Epidemiol 1993, 138(11):923-936. 32. DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS: The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol 1991, 59(2):295-304. 33. Velicer WF, Fava JL, Prochaska JO, Abrams DB, Emmons KM, Pierce JP: Distribution of smokers by stage in three representative samples. Prev Med 1995, 24(4):401-411. 34. Kristman VL, Manno M, Cote P: Methods to account for attrition in longitudinal data: do they work? A simulation study. Eur J Epidemiol 2005, 20(8):657-662. 35. Mimiaga MJ, Fair AD, Mayer KH, Koenen K, Gortmaker S, Tetu AM, Hobson J, Safren SA: Experiences and sexual behaviors of HIV-infected MSM who acquired HIV in the context of crystal methamphetamine use. AIDS Educ Prev 2008, 20(1):30-41. 36. Barresi P, Husnik M, Camacho M, Powell B, Gage R, LeBlanc D, Verano P, Chesney M, Koblin B: Recruitment of men who have sex with men for large HIV intervention trials: analysis of the EXPLORE Study recruitment effort. AIDS Educ Prev 22(1):28-36. 37. Rawson RA, McCann MJ, Flammino F, Shoptaw S, Miotto K, Reiber C, Ling W: A comparison of contingency management and cognitive- behavioral approaches for stimulant-dependent individuals. Addiction 2006, 101(2):267-274. 38. Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, et al: Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry 2005, 62(10):1148-1156. 39. Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, et al: Effects of lower- cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry 2006, 63(2):201-208. 40. Shoptaw S, Huber A, Peck J, Yang X, Liu J, Jeff D, Roll J, Shapiro B, Rotheram-Fuller E, Ling W: Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug Alcohol Depend 2006, 85(1):12-18. 41. Lee NK, Rawson RA: A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev 2008, 27(3):309-317. 42. Mimiaga MJ, Safren SA, Benet DJ, Manseau MW, DeSousa N, Mayer KH: MSM in HIV-prevention trials are sexual partners with each other: An ancillary study to the EXPLORE intervention. AIDS Behav 2006, 10(1):27-34. 43. Imrie J, Stephenson JM, Cowan FM, Wanigaratne S, Billington AJ, Copas AJ, French L, French PD, Johnson AM: A cognitive behavioural intervention to